Oscar Health, Inc. (OSCR) Stock Moves -3.22%: What You Should Know

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $18.91, marking a -3.22% move from the previous day. Meanwhile, the Dow lost 0.16%, and the Nasdaq, a tech-heavy index, added 0.55%. Shares of the company have appreciated by 3.22% over the course of the past month, outperforming the Finance sector's loss of 0.91%, and lagging the S&P 500's gain of 3.83%.Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 6, 2025. It is anticipated that the company will report an EPS of -$0.55, marking a 150% fall compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $3.09 billion, indicating a 27.51% increase compared to the same quarter of the previous year. For the full year, the Zacks Consensus Estimates are projecting earnings of -$1.42 per share and revenue of $12.06 billion, which would represent changes of -1520% and +31.44%, respectively, from the prior year. Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. presently features a Zacks Rank of #3 (Hold). The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 62, which puts it in the top 26% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. #1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks